Phibro Animal Health (PAHC) Return on Capital Employed (2014 - 2026)

Phibro Animal Health's Return on Capital Employed history runs 13 years deep, the most recent figure standing at 15.74% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 654.0% year-over-year to 15.74%; the TTM figure through Mar 2026 stood at 15.74% (up 654.0% YoY), while the FY2025 annual figure was 12.58%, up 568.0% from the prior year.
• Return on Capital Employed was 15.74% for Q1 2026 at Phibro Animal Health, up from 15.17% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 15.74% in Q1 2026 to a low of 6.87% in Q2 2024.
• Historically, Return on Capital Employed has averaged 9.97% across 5 years, with a median of 9.14% in 2024.
• The sharpest annual moves came in 2023 and 2026: Return on Capital Employed sank 295 bps in 2023, then jumped 654 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 9.09% in 2022, then declined by 19 bps to 7.34% in 2023, then increased by 25 bps to 9.14% in 2024, then soared by 66 bps to 15.17% in 2025, then climbed by 4 bps to 15.74% in 2026.
• The last three Return on Capital Employed figures came in at 15.74% (Q1 2026), 15.17% (Q4 2025), and 13.06% (Q3 2025), per Business Quant data.